Integrated Wealth Concepts’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.1K Buy
+758
New +$68.3K ﹤0.01% 3037
2025
Q1
Sell
-13,931
Closed -$916K 1792
2024
Q4
$916K Sell
13,931
-1,162
-8% -$80K 0.01% 858
2024
Q3
$1.07M Sell
15,093
-10
-0.1% -$697 0.01% 777
2024
Q2
$1M Buy
15,103
+1,290
+9% +$84.5K 0.01% 759
2024
Q1
$938K Sell
13,813
-56
-0.4% -$3.7K 0.01% 779
2023
Q4
$857K Buy
13,869
+270
+2% +$15.9K 0.01% 793
2023
Q3
$802K Sell
13,599
-162
-1% -$9.94K 0.01% 780
2023
Q2
$821K Sell
13,761
-1,587
-10% -$94.3K 0.01% 758
2023
Q1
$897K Sell
15,348
-60
-0.4% -$3.61K 0.02% 653
2022
Q4
$956K Buy
15,408
+675
+5% +$40.6K 0.03% 485
2022
Q3
$833K Buy
14,733
+435
+3% +$26.8K 0.03% 462
2022
Q2
$913K Sell
14,298
-660
-4% -$41.9K 0.03% 443
2022
Q1
$968K Buy
14,958
+447
+3% +$28.3K 0.03% 402
2021
Q4
$966K Buy
14,511
+603
+4% +$38.2K 0.03% 429
2021
Q3
$849K Buy
+13,908
New +$884K 0.03% 440

Other funds holding IHE

Integrated Wealth Concepts's IHE Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 758 shares worth $75.1K. The stake represents ﹤0.01% of the portfolio and ranks #3037 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in IHE as recently as Q4 2024.

Integrated Wealth Concepts first reported a position in IHE in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.07M in Q3 2024. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Integrated Wealth Concepts held 758 shares of iShares US Pharmaceuticals ETF worth $75.1K as of Q2 2026.
  • iShares US Pharmaceuticals ETF was a new Integrated Wealth Concepts position in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3037 holding.
  • Integrated Wealth Concepts first reported a position in iShares US Pharmaceuticals ETF in Q3 2021 and has held it in 15 quarters since.
  • Integrated Wealth Concepts's iShares US Pharmaceuticals ETF position peaked at $1.07M in Q3 2024.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.